RQ Bio secures $115M Series A for virus-targeting antibody pipeline
By
Ayisha Sharma
Source
bskyRQ Bio secures $115M Series A for virus-targeting antibody pipelineendpoints.newsYou might also wanna read
Factory Raises $50M Series B at $300M Valuation for AI Software Development Agents
Factory, an AI software development agent company, has raised $50 million in Series B funding at a $300 million valuation. The round was led
factory.ai·9mo ago
Verge Genomics Hiring for Engineering and Product Roles to Advance AI Drug Discovery
Verge Genomics, an AI drug discovery company, is hiring for multiple engineering and product roles including Head of Product & Engineering,
news.ycombinator.com·8mo ago
Investigation finds over 450 instances of apparent data manipulation in Thermo Fisher antibody catalog
An investigation by Sholto David reveals widespread apparent data manipulation in Thermo Fisher Scientific's antibody catalog. More than 450
reeserichardson.blog·16d ago
Sarvam raises $300M Series B at $1.5B valuation led by HCLTech and Bessemer
Sarvam, India's full-stack sovereign AI company, announced a $300 million Series B funding round led by HCLTech and Bessemer Venture Partner
sarvam.ai·9d ago
Groq reportedly raising $650M despite Nvidia licensing its technology and hiring key staff
Groq, the AI chip company that was thought to have been acquired by Nvidia in December 2024, is reportedly raising $650M. However, Nvidia on
zach.be·22d ago
Gemma-Based AI Model Identifies Potential Cancer Therapy Pathway Through Conditional Immune Amplification
Researchers used a new 27 billion parameter foundation model called C2S-Scale 27B, built on Google's Gemma family of open models, to discove
blog.google·8mo agoComments
Sign in to join the conversation.
No comments yet. Be the first.